#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I, II – III Burkitt's lymphoma refractory Idiopathic pulmonary fibrosis Antiphospholipid antibodies Osteosarcoma recurrent Microscopic polyangiitis Neuroendocrine cell hyperplasia of infancy Acute graft versus host disease in intestine Cytomegalovirus infection Arteriovenous malformation Cortical dysplasia Hyperphagia Primary mediastinal large B-cell lymphoma Fusarium infection Pericarditis More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Diagnostics VEXAS syndrome – Diagnostics Glomerulonephritis membranoproliferative – Basic Information Osteosarcoma recurrent Prolymphocytic leukaemia – Treatment Choroid melanoma – Life with Disease Angelman’s syndrome – Basic Information Friedreich’s ataxia – Trials in Disease Alport’s syndrome – Diagnostics Antithrombin III deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amoxicillin Trihydrate Florbetaben (18F) Ilofotase Alfa Soya Oil, Purified Zoledronic Acid Meropenem Trihydrate FLUORIDE Dl-Alpha-Tocopherol LTG-001 Demeclocycline Hydrochloride RO7284755 Abc-24F-116 D-Camphor Maralixibat Chloride Mps-103 Relacorilant [99MTC]PSMA I&S Alectinib Hydrochloride ORG-129 Caraway Oil More therapies…

    Learn about Your Condition

    Endometrial cancer recurrent Kearns-Sayre syndrome Lymphoedema Uveitis Tympanic membrane perforation Bladder cancer recurrent Cachexia Dengue fever SAPHO syndrome CADASIL Fungal infection Pancreaticoduodenectomy Hodgkin's disease Arterial disorder Netherton's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Effects and Safety of Bulevirtide, Peginterferon Alfa-2a, and Entecavir in Patients with Chronic Hepatitis D

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Entecavir
    • Tenofovir Disoproxil
    Sweden
  • Study on Valaciclovir for Treating Advanced Gum Disease in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Periodontitis
    Investigated Drugs:
    • Valaciclovir
    • Cellulose, Microcrystalline
    France
  • Study on the Effects of Dexamethasone and Oseltamivir in Patients with Severe Influenza

    Recruiting

    3 1 1
    Investigated Diseases:
    • H1N1 influenza
    Investigated Drugs:
    • Oseltamivir
    • Cellulose, Microcrystalline
    • Betamethasone Sodium Phosphate
    Spain
  • Study on Venetoclax for Reducing HIV Reservoir in Patients on Antiretroviral Therapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Venetoclax
    Denmark
  • A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Bulgaria Poland
  • Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

    Recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Colchicine
    Spain
Previous Page
1 … 13 14 15 16 17 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!